6533b7cffe1ef96bd1258fb0

RESEARCH PRODUCT

Characterization and multicentric validation of a common standard for Toxoplasma gondii detection using nucleic acid amplification assays.

Yvon SterkersLaurence DelhaesSophie CassaingHervé PellouxDenis FilisettiEmmanuelle Varlet-marieFeriel TouafekMarie-pierre Brenier-pinchartHélène YeraPatrick BastienFrédéric Dalle

subject

Microbiology (medical)MESH: Reference Standards*MESH: Molecular Diagnostic Techniques/methods*MESH: Parasite Load/standards[SDV]Life Sciences [q-bio]Toxoplasma gondiidiagnosticParasitic loadsParasite LoadMESH: Nucleic Acid Amplification Techniques/standards*MESH: Toxoplasma/isolation & purification*medicineMolecular diagnostic techniquesHumansNational levelReference standardsMESH: Parasite Load/methodsstandardizationMESH: HumansbiologyMESH: Nucleic Acid Amplification Techniques/methods*Toxoplasma gondiiNucleic acid amplification techniqueMESH: Toxoplasmosis/diagnosis*MESH: Molecular Diagnostic Techniques/standards*Reference Standardsbiology.organism_classificationmedicine.diseaseVirologyToxoplasmosisquantification3. Good healthMESH: FranceMolecular Diagnostic TechniquesImmunologyNucleic acidMESH: Toxoplasma/geneticsParasitologyFranceNucleic Acid Amplification TechniquesToxoplasmaToxoplasmosis

description

ABSTRACT The molecular diagnosis of toxoplasmosis essentially relies upon laboratory-developed methods and suffers from lack of standardization, hence the large diversity of performances between laboratories. Moreover, quantifications of parasitic loads differ among centers, a fact which prevents the possible prediction of the severity of this disease as a function of parasitic loads. The objectives of this multicentric study performed in eight proficient laboratories of the Molecular Biology Pole of the French National Reference Center for Toxoplasmosis (NRC-T) were (i) to assess the suitability of a lyophilized preparation of Toxoplasma gondii as a common standard for use in this PCR-based molecular diagnosis and (ii) to make this standard available to the community. High-quality written procedures were used for the production and qualification of this standard. Three independent batches of this standard, containing concentrations ranging from 10 4 to 0.01 T. gondii genome equivalents per PCR, were first assessed: the linear dynamic range was ≥6 log, the intra-assay coefficients of variation (CV) from a sample containing 10 T. gondii organisms per PCR were 0.3% to 0.42%, and the interassay CV over a 2-week period was 0.76% to 1.47%. A further assessment in eight diagnostic centers showed that the standard is stable, robust, and reliable. These lyophilized standards can easily be produced at a larger scale when needed and can be made widely available at the national level. To our knowledge, this is the first quality control assessment of a common standard which is usable both for self-evaluation in laboratories and for accurate quantification of parasitic loads in T. gondii prenatal infections.

10.1128/jcm.01906-14https://pubmed.ncbi.nlm.nih.gov/25187637